The dysregulation and/or hyperactivation of the EGFR signaling pathway are frequently found in epithelial lung tumor entities, in which the hyperactivated EGFR signaling is associated with advanced lung cancer and poor prognosis [6]. This evidence concerns the gene EGFR and lung cancer.